1.A clinical evalustion of uterine prolapse.
Sung Won LEE ; Yong JO ; Byung Tae MOON ; Eui Sun RO ; Yong Pil KIM ; Soon Wook KWON
Korean Journal of Obstetrics and Gynecology 1993;36(7):1376-1382
No abstract available.
Uterine Prolapse*
2.Distribution of Tyrosine Hydroxylse Immunoreactive Structure in the Spinal Cord and Dorsal Root Ganglion of the Rat.
Yong Joo KIM ; Ji Yoon KIM ; Dong Sun KIM ; Hee Joong JO ; Yong Chul BAE ; Mae Ja PARK
Korean Journal of Anatomy 1997;30(2):147-153
With the aim of gaining more insight into the catecholaminergic system in the nervous system of the rat, we have studied the precise distribution pattern of the tyrosine hydroxylase immunoreactive[TH-IR] fibers and soma in the spinal cord and dorsal root ganglion. In the dorsal root ganglion[DRG], TH-IR fibers were observed to run along the vessel wall, spirally and not found in the neural tissue itself. A few TH-IR fibers were found in the spinal nerve, not in the ventral root. Many TH-IR neurons were distributed in the L3, 4, 5, and 6 DRG but none of them were found in the other DRG segments. In the spinal cord, TH-IR fibers have shown sparse distribution all over spinal cord but relatively dense distribution in the ventral horn, intermediolateral column, lamina I of the dorsal horn of the cervical, lumbar, sacral, and coccygeal segment. TH-IR neurons were found in the intermediolateral column, dorsal gray commissure, dorsal horn of the C1 and C2 segments and S1-4 segments. TH-IR neurons in the cervical segments were polygonal and spindle shaped with well developed processes. In contrast to this, TH-IR neurons in the sacral segments were oval or spindle shaped with no processes. In conclusion, neurons in the DRG were not influenced by catecholaminergic nervous input. Intrinsic catecholaminergic nervous systems were found in both of spinal cord and DRG.
Animals
;
Carisoprodol
;
Diagnosis-Related Groups
;
Ganglia, Spinal*
;
Horns
;
Immunohistochemistry
;
Nervous System
;
Neurons
;
Rats*
;
Spinal Cord*
;
Spinal Nerve Roots*
;
Spinal Nerves
;
Tyrosine 3-Monooxygenase
;
Tyrosine*
3.A Comparative Analysis of Cervical Pap Smears Prepared by Conventional and ThinPrep Method.
Yeon Hwa LA ; Gyung Chul JO ; Sung Tae HAN ; Suk Hee JUNG ; Jung Rae SEO ; Woo Chul JUNG ; Sung Won LEE ; Yong JO ; Eui Sun RO
Korean Journal of Obstetrics and Gynecology 2000;43(8):1450-1458
No abstract available.
5.A Case of Anterior Urethral Valve.
Yung Sun UH ; Yong Hyun PARK ; Yong Kyu JO ; Moon Soo YOON ; Sung Yung CHUNG
Korean Journal of Urology 1972;13(4):301-303
A 10-year-old boy presented with dribbling on urination, intermittent left flank pain and pyuria since birth. With voiding cystourelhrography this case was diagnosed as congenital anterior urethral valve which was confirmed by panendoscopic study. He was underwent electrocoagulation of the valve and left nephrectomy. And so he was discharged with good urinary stream on the 23 rd postoperative day.
Child
;
Electrocoagulation
;
Flank Pain
;
Humans
;
Male
;
Nephrectomy
;
Parturition
;
Pyuria
;
Rivers
;
Urination
6.A Case of Gerstmann-Straussler-Scheinker Disease.
Min Jeong PARK ; Hee Young JO ; Sang Myung CHEON ; Sun Seob CHOI ; Yong Sun KIM ; Jae Woo KIM
Journal of Clinical Neurology 2010;6(1):46-50
BACKGROUND: Gerstmann-Straussler-Scheinker disease (GSS) is a type of human transmissible spongiform encephalopathy (TSE) that is determined genetically. CASE REPORT: A 46-year-old woman presented with a slowly progressive ataxic gait and cognitive decline. She was alert but did not cooperate well due to severe dementia and dysarthria. High signal intensities in the cerebral cortices were evident in MRI, especially in diffusion-weighted images (DWI). A prion protein gene (PRNP) analysis revealed a P102L (proline-to-leucine) mutation in codon 102. CONCLUSIONS: This is the first reported case of GSS (confirmed by PRNP analysis) in Korea. Distinctive MRI findings are also presented.
Cerebral Cortex
;
Codon
;
Dementia
;
Dysarthria
;
Female
;
Gait
;
Gerstmann-Straussler-Scheinker Disease
;
Humans
;
Korea
;
Middle Aged
;
Prion Diseases
7.Factors Predicting the Development of Radiation Pneumonitis in the Patients Receiving Radiation Therapy for Lung Cancer.
Jin Yong AN ; Sun Jung KWON ; Yun Sun LEE ; Hee Sun PARK ; Sung Soo JUNG ; Jin Whan KIM ; Ju Ock KIM ; Moon Jun JO ; Sun Young KIM
Tuberculosis and Respiratory Diseases 2004;56(1):40-50
BACKGROUND: Radiation pneumonitis(RP) is the major serious complication of thoracic irradiation treatment. In this study, we attempted to retrospectively evaluate the long-term prognosis of patients who experienced acute RP and to identify factor that might allow prediction of RP. METHODS: Of the 114 lung cancer patients who underwent thoracic radiotherapy between December 2000 and December 2002, We performed analysis using a database of 90 patients who were capable of being evaluated. RESULTS: Of the 44 patients(48.9%) who experienced clinical RP in this study, the RP was mild in 33(36.6%) and severe in 11(12.3%). All of severe RP were treated with corticosteroids. The median starting corticosteroids dose was 34 mg(30~40) and median treatment duration was 68 days(8~97). The median survival time of the 11 patients who experienced severe RP was significantly poorer than the mild RP group. (p=0.046) The higher total radiation dose(>or=60 Gy) was significantly associated with developing in RP.(p=0.001) The incidence of RP did not correlate with any of the ECOG performance, pulmonary function test, age, cell type, history of smoking, radiotherapy combined with chemotherapy, once-daily radiotherapy dose fraction. Also, serum albumin level, uric acid level at onset of RP did not influence the risk of severe RP in our study. CONCLUSION: Only the higher total radiation dose(>or=60 Gy) was a significant risk factor predictive of RP. Also severe RP was an adverse prognostic factor.
Adrenal Cortex Hormones
;
Drug Therapy
;
Humans
;
Incidence
;
Lung Neoplasms*
;
Lung*
;
Prognosis
;
Radiation Pneumonitis*
;
Radiotherapy
;
Respiratory Function Tests
;
Retrospective Studies
;
Risk Factors
;
Serum Albumin
;
Smoke
;
Smoking
;
Uric Acid
8.Etiology and outcomes of anuria in acute kidney injury: a single center study.
Hye Min CHOI ; Sun Chul KIM ; Myung Gyu KIM ; Sang Kyung JO ; Won Yong CHO ; Hyoung Kyu KIM
Kidney Research and Clinical Practice 2015;34(1):13-19
BACKGROUND: It was previously known that anuric acute kidney injury (AKI) is uncommon and its occurrence suggests complete ureteral obstruction, shock, or a major vascular event. As the epidemiology of AKI has significantly changed over the past decade, it is possible that the incidence, etiology, or clinical characteristics of anuric AKI have also changed. METHODS: A prospective cohort study was conducted that included all patients undergoing renal replacement therapy (RRT) for AKI during a 2-year period in a tertiary hospital. Patients were classified as having anuric, oliguric, or nonoliguric AKI based on their volume of urine when RRT started using the modified Acute Kidney Injury Network criteria. RESULTS: Of the 203 patients included in the study, 21.2% met the criteria for anuric AKI. Septic and postoperative AKI were the main causes of anuric AKI, with 60.5% of incidences occurring in hospital. Anuric AKI was associated with a younger age, a lower prevalence of pre-morbid chronic kidney disease and diabetes, more frequent continuous RRT requirement, and multi-organ dysfunction. In addition, patients with anuric AKI had a higher rate of in-hospital mortality and long-term dependence on RRT than patients with nonanuric AKI. CONCLUSION: Anuric AKI is common, with sepsis as the main etiological insult, and is associated with adverse outcomes among patients with AKI who require RRT.
Acute Kidney Injury*
;
Anuria*
;
Cohort Studies
;
Epidemiology
;
Hospital Mortality
;
Humans
;
Incidence
;
Oliguria
;
Prevalence
;
Prospective Studies
;
Renal Insufficiency, Chronic
;
Renal Replacement Therapy
;
Sepsis
;
Shock
;
Tertiary Care Centers
;
Ureteral Obstruction
9.Congenital Bronchoesophageal Fistula Causing Only Chronic Cough: One case.
Myung Sun JOO ; Seung Min KWAK ; Chul Ho JO ; Yong Woon SHIN ; Sae Whan KIM
Tuberculosis and Respiratory Diseases 1996;43(5):812-817
There were so many causes of chronic coughing including postnasal drip, pneumonia, nasal polyp, asthma, interstinal lung disease etc. Congenital bronchoesophageal fistula was not usually thought as cause of chronic coughing. A 46-year-old female patient suffered from chronic coughing without usual causes. Her chest X-ray viewed normally. She coughed especially after swallowing foods. So we recommended her esophagogram and it revealed broncho-esphageal fistula. She underwent surgical resection of broncho-esophageal fistula. She was well without cough after the surgery. We reported a case of congenital broncho-esphageal fistula that had caused chronic coughing without any evidence of pneumonia, malignancy, tuberculosis, bronchiectasis, inflammation, asthma, nasal polyp, etc. So we should suspect the bronchoesophageal fistula when patients cough chronically with eating, and recommend the esophagogram.
Asthma
;
Bronchiectasis
;
Cough*
;
Deglutition
;
Eating
;
Female
;
Fistula*
;
Humans
;
Inflammation
;
Lung Diseases
;
Middle Aged
;
Nasal Polyps
;
Pneumonia
;
Thorax
;
Tuberculosis
10.Evaluation of short-term Hypolipidemic Effect and Safety of Simvastatin(Zocor(R)) in Patients with Hyperlipidemia.
Min Kyoung KIM ; Yong Ho PARK ; Jong sun PARK ; Dong Gu SHIN ; Young Jo KIM ; Gi Sik KIM
Yeungnam University Journal of Medicine 2003;20(2):152-159
BACKGROUND: Hyperlipidemia is the one of the major risk factors causing the atherosclerosis of coronary arteries. Treatment of hyperlipidemia with drugs has been confirmed the effects of therapy showing a decreased incidence of coronary artery disease. Simvastatin is a new drug of HMG-CoA reductase inhibitors and the short-term hypolipidemic effects and safety of simvastatin is evaluated in patients with hyperlipidemia. METHODS: We studied 63 patients (39 males and 24 females, mean age 58) for 12 weeks whose plasma levels of total cholesterol were higher than 240 mg/dL or higher than 220 mg/dL with ischemic heart disease. Simvastatin was administered 20 mg/day and measured lipid profile at 12 week interval. RESULT: 1)Simvastatin significantly reduced the level of the plasma total cholesterol(-29.3%), LDL- cholesterol(-36.9%) and triglyceride(-13%)(p<0.05) but the level of HDL-cholesterol was not changed after 12 weeks simvastatin therapy. 2)the clinical symptoms and laboratory examination before and after simvastatin treatment showed no particular abnormal findings in short term follow up. CONCLUSION: These results suggested that short-term simvastatin therapy in patients with hyperlipidemia seeems to be very effective and safe.
Atherosclerosis
;
Cholesterol
;
Coronary Artery Disease
;
Coronary Vessels
;
Female
;
Follow-Up Studies
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Hyperlipidemias*
;
Incidence
;
Male
;
Myocardial Ischemia
;
Plasma
;
Risk Factors
;
Simvastatin